Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis.

Tiihonen J, Wahlbeck K, Kiviniemi V.

Schizophr Res. 2009 Apr;109(1-3):10-4. doi: 10.1016/j.schres.2009.01.002. Epub 2009 Jan 30. Review.

PMID:
19186030
2.

Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review.

Sommer IE, Begemann MJ, Temmerman A, Leucht S.

Schizophr Bull. 2012 Sep;38(5):1003-11. doi: 10.1093/schbul/sbr004. Epub 2011 Mar 21. Review.

3.

Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials.

Goff DC, Keefe R, Citrome L, Davy K, Krystal JH, Large C, Thompson TR, Volavka J, Webster EL.

J Clin Psychopharmacol. 2007 Dec;27(6):582-9.

PMID:
18004124
4.

Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment.

Vayısoğlu S, Anıl Yağcıoğlu AE, Yağcıoğlu S, Karahan S, Karcı O, Gürel SC, Yazıcı MK.

Schizophr Res. 2013 Jan;143(1):207-14. doi: 10.1016/j.schres.2012.11.006. Epub 2012 Dec 2.

PMID:
23217729
5.

Addition of lamotrigine to clozapine in inpatients with chronic psychosis.

Heck AH, de Groot IW, van Harten PN.

J Clin Psychiatry. 2005 Oct;66(10):1333. No abstract available.

PMID:
16259551
6.

The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: a double-blind, placebo-controlled study.

Zoccali R, Muscatello MR, Bruno A, Cambria R, Micò U, Spina E, Meduri M.

Schizophr Res. 2007 Jul;93(1-3):109-16. Epub 2007 Mar 26.

PMID:
17383857
7.

Clozapine plus lamotrigine in treatment-resistant schizophrenia.

Dursun SM, McIntosh D, Milliken H.

Arch Gen Psychiatry. 1999 Oct;56(10):950. No abstract available.

PMID:
10530638
8.

Clozapine versus typical neuroleptic medication for schizophrenia.

Essali A, Al-Haj Haasan N, Li C, Rathbone J.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD000059. doi: 10.1002/14651858.CD000059.pub2. Review.

PMID:
19160174
9.

Lamotrigine for schizophrenia.

Premkumar TS, Pick J.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005962. Review.

PMID:
17054266
10.

Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.

Taylor DM, Smith L.

Acta Psychiatr Scand. 2009 Jun;119(6):419-25. doi: 10.1111/j.1600-0447.2009.01367.x. Epub 2009 Feb 25.

PMID:
19245679
11.

Clozapine versus typical neuroleptic medication for schizophrenia.

Wahlbeck K, Cheine M, Essali MA.

Cochrane Database Syst Rev. 2000;(2):CD000059. Review. Update in: Cochrane Database Syst Rev. 2009;(1):CD000059.

PMID:
10796289
12.

Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials.

Correll CU, Rummel-Kluge C, Corves C, Kane JM, Leucht S.

Schizophr Bull. 2009 Mar;35(2):443-57. doi: 10.1093/schbul/sbn018. Epub 2008 Apr 15.

13.

Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials.

Zheng W, Xiang YT, Yang XH, Xiang YQ, de Leon J.

J Clin Psychiatry. 2017 May;78(5):e498-e505. doi: 10.4088/JCP.16r10782.

PMID:
28355041
14.

Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia.

Kremer I, Vass A, Gorelik I, Bar G, Blanaru M, Javitt DC, Heresco-Levy U.

Biol Psychiatry. 2004 Sep 15;56(6):441-6.

PMID:
15364042
15.

Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia.

Singh SP, Singh V.

CNS Drugs. 2011 Oct 1;25(10):859-85. doi: 10.2165/11586650-000000000-00000.

PMID:
21936588
16.
17.

Placebo-controlled trial of glycine added to clozapine in schizophrenia.

Evins AE, Fitzgerald SM, Wine L, Rosselli R, Goff DC.

Am J Psychiatry. 2000 May;157(5):826-8.

PMID:
10784481
19.

Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.

de Lucena D, Fernandes BS, Berk M, Dodd S, Medeiros DW, Pedrini M, Kunz M, Gomes FA, Giglio LF, Lobato MI, Belmonte-de-Abreu PS, Gama CS.

J Clin Psychiatry. 2009 Oct;70(10):1416-23. doi: 10.4088/JCP.08m04935gry. Erratum in: J Clin Psychiatry. 2011 Aug;72(8):1157.

PMID:
19906345
20.

Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.

Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B.

Am J Psychiatry. 2001 Apr;158(4):518-26.

PMID:
11282684

Supplemental Content

Support Center